On 24 July, one of our most cherished researchers, Roger, had the opportunity to defend his PhD thesis, titled “Exploring Strategies for Drug Discovery Against Challenging Targets in Oncology”. After years of hard work, dedication, and learning, he has finally done it! Congratulations, Dr. Castaño! We are incredibly proud of you and wish you all […]

Read More →

Galdeano Lab PhD students Ana Buj, Joel Muixí, and Tomás Muñoz had the opportunity to present their work at the annual SEQT Young Researcher Symposium in Valencia on 10 July. This was a great opportunity for the three newly arrived researchers to share their work and exchange ideas with other students and professors from across […]

Read More →

Joel Muixi and Ana Buj took part in the PhD day at the Univeristy of Barcelona. Ana presented her research through a short monologue, explaining her thesis in just four minutes. Joel contributed with an outreach poster and was awarded the prize for best poster. We warmly congratulate both for their great work and representation […]

Read More →

The Drug Discovery Chemistry Europe conference, held last week in Barcelona, brought together leading scientists in medicinal chemistry, chemical biology, and early drug discovery. Prof. Carles Galdeano delivered a talk titled “From Exploiting Binding Sites on E3 Ligases to Developing Allosteric Modulators of the FBW7 E3 Ligase,” where he presented the group’s latest advances in […]

Read More →

Dr. Carles Galdeano recently participated in the Discovery On Target 2025 international conference held in Boston (USA), where he presented his work titled “A First-in-Class TET2 Activator as a New Therapeutic Strategy Against Cancer.” During his talk, he introduced the development of a pioneering TET2 activator as a novel therapeutic approach against cancer, showing promising […]

Read More →

Members of Galdeano’s Lab recently participated in the congresses organized by the European Federation for Medicinal Chemistry and Chemical Biology (EFMC) in Porto. Dr. Anna Sampietro attended the EFMC-ASMC International Symposium on Advances in Synthetic and Medicinal Chemistry, where she presented a poster showcasing the latest results from the group’s ongoing research. Subsequently, Dr. Anna […]

Read More →

We have published a new paper in the group, where we evaluated the applicability of Dynamic Undocking to predict relative binding free energy in a fast and efficient manner.  

Read More →

We attended to the “Fourth Annual Meeting of the ProteoCure COST Action” that was hold in Heraklion, Crete from 20th to 23rd May 2025. Carles gave a talk about “Targeting allosteric binding sites in E3 ligases: Novel FBW7 modulators“. Andrea gave a flash poster presentation and presented her poster about her PhD project “Allosteric modulation […]

Read More →

On April 25th, 2025, Anna Sampietro successfully defended their doctoral thesis entitled “Exploring Novel Target Combinations for Treating Neurodegenerative Diseases.” We warmly congratulate Anna for this achievement and their valuable contributions to the field of medicinal chemistry.  

Read More →

Tuo participated in the 1st meeting of Organic Chemistry of the Catalan Chemical Society (1RQO-SQC). He presented a poster about the research he is doing during his thesis and he was awarded with the best poster presentation.

Read More →